Drew Lyall was the inaugural executive director of the Stem Cell Network and, over 12 years, helped build it into an internationally respected research and development powerhouse. He died in January 2016, in Ottawa, a few days shy of his 50th birthday after an eight-year battle with melanoma.
Dr. Michael Rudnicki believes Mr. Lyall’s professional legacy is the community of stem cell scientists spread across Canada who agreed to work together collaboratively under the Stem Cell Network banner. “The nature of the community reflected who he was and how he dealt with people.”
Dr. Janet Rossant describes Drew as “a true stem cell hero”. “He was the glue that brought the Network together, whether driving the science, advocating on the Hill for a cord blood stem cell bank, or leading the party at the annual Network pub night.”
To honour Drew’s memory, and to recognize his legacy, in 2016 the Stem Cell Network inaugurated the Drew Lyall Award of Excellence. This award is presented annually at the Till & McCulloch Meetings to the lead author of the highest ranked abstract in the abstract competition, and is accompanied by the delivery of the Drew Lyall Award of Excellence talk.
Dr. Songtao Dong, was the recipient of the 2026 Drew Lyall Award of Excellence for his work as lead author on “Systemic muscle-targeted lipid nanoparticles edit muscle stem cells and improve cardiac and diaphragm pathology in Duchenne muscular dystrophy.”
Dr. Dong is a Postdoctoral Research Fellow in the Li Lab at the Leslie Dan Faculty of Pharmacy, University of Toronto. His research focuses on developing ionizable lipid nanoparticles to deliver mRNA and other nucleic acid cargos for applications including genome editing, RNA editing, cancer immunotherapy and the treatment of genetic diseases.
Dr. Dong accepted his award and presented the Drew Lyall Award of Excellence talk on November 10 at the 2026 Till & McCulloch Meetings in Vancouver.
350 Albert Street,
Suite 325
Ottawa, ON
K1R 1A4
info@stemcellnetwork.ca
Receive the latest news on SCN funding programs and training opportunities, and what’s happening in the stem cell industry, directly in your inbox.
Newsletter sign-up form